{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T05:13:49Z","timestamp":1737177229041,"version":"3.33.0"},"reference-count":0,"publisher":"Tunisian Society of Medical Sciences","issue":"11","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tunis Med"],"abstract":"<jats:p>Objectifs\u00a0: Analyser les caract\u00e9ristiques de la prescription des bioth\u00e9rapies (bDMARDs) au cours des rhumatismes inflammatoires chroniques (RIC), pris en charge par la Caisse Nationale d'Assurance Maladie (CNAM) en Tunisie, estimer son co\u00fbt direct et les facteurs qui en sont associ\u00e9s.\nM\u00e9thodes\u00a0: Cent neuf dossiers, cons\u00e9cutifs, de premi\u00e8re prescription ou de rotation de bDMARDs, de Janvier \u00e0 Juin 2022, ont \u00e9t\u00e9 inclus. Les param\u00e8tres cliniques, th\u00e9rapeutiques et d\u00e9terminant le choix, ont \u00e9t\u00e9 collect\u00e9s. Les co\u00fbts mensuels de bDMARDs ont \u00e9t\u00e9 calcul\u00e9s.\u00a0 Le surco\u00fbt est d\u00e9fini par un co\u00fbt d\u00e9passant 2200 dinars Tunisien (DT) par mois par patient.\nR\u00e9sultats\u00a0: Le RIC \u00e9tait, essentiellement, une spondyloarthrite axiale (SA) dans 44% et une polyarthrite rhumato\u00efde (PR) dans 37,6% des cas. L\u2019arthrite idiopathique juv\u00e9nile repr\u00e9sentait 2,7% des cas.\u00a0 Les bDMARDs \u00e9tait prescrits majoritairement dans les r\u00e9gions c\u00f4ti\u00e8res, suivant la r\u00e9partition des rhumatolgues. Le certolizumab p\u00e9gol \u00e9tait le plus prescrit dans 45% des cas. Les d\u00e9penses mensuelles totales en bDMARDs sont estim\u00e9es \u00e0 225 535 \u00b1 1269 DT. Aucune association significative n\u2019\u00e9tait observ\u00e9e entre le choix de la mol\u00e9cule de bDMARDs et les caract\u00e9ristiques des patients, ni des RIC, ni des prescripteurs. Le surco\u00fbt \u00e9tait associ\u00e9 de fa\u00e7on significative au DAS28 initial \u00e9lev\u00e9 lors de la PR et \u00e0 l\u2019\u00e2ge jeune et la proth\u00e8se totale de la hanche au cours de la SA.\nConclusion\u00a0: En Tunisie, la prescription des bDMARDs est in\u00e9gale en fonction des r\u00e9gions et entraine un co\u00fbt \u00e9lev\u00e9. Le RIC le plus fr\u00e9quemment trait\u00e9 est la SA. \u00a0\n\u00a0<\/jats:p>","DOI":"10.62438\/tunismed.v102i11.5059","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T14:41:53Z","timestamp":1737124913000},"source":"Crossref","is-referenced-by-count":0,"title":["La prescription des bioth\u00e9rapies en Tunisie au cours des rhumatismes inflammatoires chroniques"],"prefix":"10.62438","volume":"102","author":[{"given":"Saoussen","family":"Zrour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani","family":"Dridi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rim","family":"Grassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narimane","family":"Ben Chekaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Bejia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"31112","published-online":{"date-parts":[[2024,10,30]]},"container-title":["La Tunisie M\u00e9dicale"],"original-title":[],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T14:41:53Z","timestamp":1737124913000},"score":1,"resource":{"primary":{"URL":"https:\/\/latunisiemedicale.com\/index.php\/tunismed\/article\/view\/5059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":0,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,10,30]]}},"URL":"https:\/\/doi.org\/10.62438\/tunismed.v102i11.5059","relation":{},"ISSN":["2724-7031","0041-4131"],"issn-type":[{"value":"2724-7031","type":"electronic"},{"value":"0041-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,30]]}}}